High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial

作者：Jiayi Yu, Leilei Jiang, Lina Zhao, Xue Yang, Xiaomin Wang, Dan Yang, Minglei Zhuo, Hanxiao Chen, Wei Huang, Zhengfei Zhu, Min Zhang, Yipeng Song, Quanfu Li, Zhanshu Ma, Qifeng Wang, Yanli Qu, Rong Yu, Huiming Yu, Jun Zhao, Jun Zhao, Anhui Shi, Anhui Shi, Jiayi Yu, Leilei Jiang, Lina Zhao, Xue Yang, Xiaomin Wang, Dan Yang, Minglei Zhuo, Hanxiao Chen, Wei Huang, Zhengfei Zhu, Min Zhang, Yipeng Song, Quanfu Li, Zhanshu Ma, Qifeng Wang, Yanli Qu, Rong Yu, Huiming Yu, Li Chu, Yun Bai, Yidian Zhao, Jinghua Luo, WenLi Chen, Tao Gu, Shixin Liu, Jun Yang, Yiqun Wu, Jun Zhao, Jun Zhao, Anhui Shi, Anhui Shi · 发表于：The Lancet Respiratory Medicine · 年份：2024 · DOI：10.1016/s2213-2600(24)00189-9 · 被引用次数：43 · 研究领域：Lung Cancer Research Studies、Lung Cancer Treatments and Mutations、Neuroendocrine Tumor Research Advances